Phreesia

PHR

Market cap $1.45B

Overview Fund Activity

24.19 USD

+0.91

3.91%

At close Updated Sep 18, 4:00 PM EDT

Pre-market

After hours

24.19

0.00

0%

1 day

3.91%

5 days

-4.27%

1 month

-16.87%

3 months

-5.73%

6 months

-11.29%

Year to date

-3.97%

1 year

0.58%

5 years

-18.99%

10 years

-3.55%

About: Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

Employees: 2,082

Healthcare Health Information Services

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 9 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

69% more call options, than puts

Call options by funds: $6.41M | Put options by funds: $3.78M

47% more repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 62

16% more capital invested

Capital invested by funds: $1.44B [Q1] → $1.67B (+$226M) [Q2]

2.56% more ownership

Funds ownership: 95.85% [Q1] → 98.41% (+2.56%) [Q2]

6% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 35

0% more funds holding

Funds holding: 219 [Q1] → 220 (+1) [Q2]

See Fund Rankings

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$32

32% upside

Avg. target

$35

44% upside

High target

$38

57% upside

9 analyst ratings

9 positive

100%

0 neutral

0%

0 negative

0%

Truist Securities Jailendra Singh	$36	Buy Maintained	8 Sep 2025
JMP Securities Silvan Tuerkcan	$34	Market Outperform Maintained	8 Sep 2025
Canaccord Genuity Richard Close	$38	Buy Maintained	5 Sep 2025
DA Davidson Lucky Schreiner	$33	Buy Assumed	5 Sep 2025
Piper Sandler Jessica Tassan	$34	Overweight Maintained	5 Sep 2025
Needham Ryan MacDonald	$35	Buy Maintained	5 Sep 2025
Stephens & Co. Jeff Garro	$32	Overweight Reiterated	3 Sep 2025
Mizuho Steven Valiquette	$36	Outperform Initiated	27 Aug 2025
Keybanc Aleksey Yefremov	$35	Overweight Maintained	14 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 12 articles about PHR published over the past 30 days

Becker's Names Phreesia's Sara DiNardo as one of 2025's Rising Stars of Healthcare

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that Sara DiNardo, Vice President of Client Solutions, has been named in Becker's Hospital Review's 2025 list of Rising Stars.

Becker's Names Phreesia's Sara DiNardo as one of 2025's Rising Stars of Healthcare

Holding Phreesia Despite Initial Post-Earnings Disappointment

Phreesia's stock fell post-earnings for the first time since June 2024 amid apparent disappointment with the company's largest-ever acquisition. Yet improving cash flow margin and net income trends continue to make the stock a buy. This non-cyclical growth story still has plenty of runway as the company works to expand into its large TAM opportunities.

Holding Phreesia Despite Initial Post-Earnings Disappointment

Phreesia Analysts Raise Their Forecasts After Q2 Results

Phreesia, Inc. PHR posted mixed results for the second quarter on Thursday.

Phreesia Analysts Raise Their Forecasts After Q2 Results

Analysts Weigh Integration Risks As Phreesia Expands With New Deal

Phreesia Inc. PHR shares slipped Friday despite a stronger-than-expected second quarter. The healthcare software firm posted earnings of 1 cent per share, topping forecasts for a 6 cent loss, while revenue rose 15% year-over-year to $117.26 million, ahead of estimates.

Analysts Weigh Integration Risks As Phreesia Expands With New Deal

Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript

Phreesia, Inc. (NYSE:PHR ) Q2 2026 Earnings Call September 4, 2025 5:00 PM EDT Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Co-Founder, CEO & Director Conference Call Participants Jared Haase - William Blair & Company L.L.C., Research Division Jailendra Singh - Truist Securities, Inc., Research Division Jeffrey Garro - Stephens Inc., Research Division Richard Close - Canaccord Genuity Corp., Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Jessica Tassan - Piper Sandler & Co., Research Division Ryan MacDonald - Needham & Company, LLC, Research Division Daniel Grosslight - Citigroup Inc., Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Brian Tanquilut - Jefferies LLC, Research Division Gene Mannheimer Presentation Operator Good morning, ladies and gentlemen, and welcome to the Phreesia's Second Quarter Fiscal 2026 Earnings Call.

Phreesia, Inc. (PHR) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Phreesia (PHR) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Phreesia (PHR) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks Investment Research

Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates

Phreesia (PHR) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to a loss of $0.31 per share a year ago.

Phreesia (PHR) Q2 Earnings and Revenues Beat Estimates

Phreesia Announces Second Quarter Fiscal 2026 Results

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2025. “I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the futur.

Phreesia Announces Second Quarter Fiscal 2026 Results

Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia”), a trusted leader in patient activation, today announced it has entered into a definitive agreement to acquire AccessOne Parent Holdings, Inc. (together with its subsidiaries, “AccessOne”), a portfolio company of Frontier Growth, for aggregate consideration of $160 million in cash (the “AccessOne Acquisition”). The transaction is expected to close during the third quarter or early fourth quarter of Phr.

Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions

Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces the launch of Phreesia VoiceAI, an always-on, intelligent AI phone solution purpose-built for healthcare.

Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare

See News Rankings

Charts implemented using Lightweight Charts™